CAPS

CAS No. 1135-40-6

CAPS( —— )

Catalog No. M35875 CAS No. 1135-40-6

CAPS (N-Cyclohexyl-3-aminopropanesulfonic acid) is a surfactant that acts as a chemiluminescence enhancer and can be used in the development of deep-sea in situ analyzers.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    CAPS
  • Note
    Research use only, not for human use.
  • Brief Description
    CAPS (N-Cyclohexyl-3-aminopropanesulfonic acid) is a surfactant that acts as a chemiluminescence enhancer and can be used in the development of deep-sea in situ analyzers.
  • Description
    CAPS, cyclohexylaminopropane sulfonic acid, is a surfactant. CAPS can be used as biological buffer (0.05 M, pH 11) for dialysis.
  • In Vitro
    CAPS surfactant bears a single neyative charge since the amine is not ionized at high pH.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1135-40-6
  • Formula Weight
    221.32
  • Molecular Formula
    C9H19NO3S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?H2O : 125 mg/mL (564.79 mM; Ultrasonic)DMSO : 5 mg/mL (22.59 mM; Ultrasonic )
  • SMILES
    OS(=O)(=O)CCCNC1CCCCC1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Bedard P R, et al. Ion Interaction: The Energetics and Mechanism of The Competitive Behavior Between Two Similarly Charged Molecules. 1. The Effect of Ionic Strength, Acetonitrile and Surfactant Concentration[J]. Journal of Liquid Chromatography, 1985, 8(13):2417-2443.
molnova catalog
related products
  • Parishin C

    Parishin C is a phenolic glycoside and a major component of G. elata have antioxidant property.

  • Prepro TRH (83-106)

    Prepro TRH (83-106)

  • Felzartamab

    Felzartamab(MOR-202) is a human-targeted monoclonal antibody to CD38 for the study of multiple myeloma and advanced antibody-mediated rejection of allogeneic kidney transplants.